Outcomes Associated with Time in Therapeutic Range for Patients Receiving Intravenous Unfractionated Heparin

Outcomes Associated with Time in Therapeutic Range for Patients Receiving Intravenous Unfractionated Heparin

Time in therapeutic range (TTR) with intravenous unfractionated heparin (UFH) and its association with outcomes is poorly explored. UFH can be monitored with anti-Xa or aPTT, however, evidence indicates anti-Xa monitoring of UFH improves time to therapeutic anticoagulation. The objective of this stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Mujtaba Mahmud PharmD, Maia Klimatcheva PharmD, Angela Tsang PharmD, Andrew La PharmD, Victoria Miklus PharmD, Jack Becker PharmD, Benjamin Herrmann PharmD, Amanda Cremeans PharmD, Neal J Benedict PharmD, Carlo J Iasella PharmD, MPH, BCPS, Roy E Smith MD, James C Coons PharmD, FCCP, FACC, BCCP
Format: Article
Language:English
Published: SAGE Publishing 2025-08-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296251371003
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1177/10760296251371003

Similar Items